Fish jumped out and bought the German medical enterprise

Recently, according to foreign media reports, Jiangsu Fish Leap Group (hereinafter referred to as Fish Leap Medical), in mid-February through its subsidiary in Tutlingen, Germany, Yuwell GermanyGmbH acquired the german town of Rotweil Metrox LLC shares.
According to relevant information, Metrax was founded in 1973, with 80 employees, from 1989 began to develop, produce and sell emergency medical products, including primeDIC Pmecon automatic defibrillator (AED) and professional defibrillator for emergency centers and hospital clinics, it is understood that after the acquisition, Matrax's former general manager Tobias Mohry will be retained.
fact, the acquisition began in early February.
February 7th, Fish Leap Medical announced a capital increase for its German subsidiary, Yuwell Germany GmbH, with a self-financing capital increase of no more than 20 million euros, after which Yuwell Germany registered capital of no more than 30 million euros.
announcement shows that Yuwell Germany GmbH was founded in 2016, the head of the enterprise is Bucher, Wu Qun, registered capital of 500,000 euros, operating scope for the production and sale of medical equipment, investment and investment management of other companies, in 2016, Yuwell Germany GmbH company's operating income of about 2.5 million, net profit of about 36.3 million yuan.
, although seriously insolvent, but Fish Leap Medical said that to open up overseas markets, the implementation of internationalization strategy has been the company's direction. Yuwell Germany GmbH has been established for one year as a research and development, manufacturing and business development center in Europe, facilitating the in-depth understanding and involvement of domestic executives and core technicians in the European medical device ecosystem, while the subsidiary's management team actively collects industry-leading information and seeks overseas business cooperation and mergers and acquisitions opportunities, with initial results.
can be seen that the acquisition of Metrox has a direct and inevitable link to the capital increase.
Is not an exception to the acquisition of a subsidiary overseas and then through a subsidiary, On January 26, 2017, Fosun Pharma announced that Fosun Industrial, a wholly owned subsidiary of Fosun Industries, and Fosun International, a wholly owned subsidiary of Fosun Industrial, jointly funded the establishment of a new S in Sweden. Fosun Pharma will take a stake in Breas, Europe's leading respiratory device brand, and enter the respiratory market through the PV joint venture, which will invest no more than US$90 million (RMB619 million) in goldcodup through the transfer of shares and the subscription of additional shares through SPV. (Cypress Blue Equipment)